October 4, 2022 — The American Heart Association (AHA) Scientific Sessions 2022 is set for November 5-7 at McCormick Place in Chicago, and virtually. On November 4, a Pre-session Symposia and Early Career Day will take place.


The 34th Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research Foundation (CRF), was held Sept. 16-20 in Boston, MA. For those of us on hand for the event, and others who participated virtually, it was clear how TCT has become the premier educational meeting specializing in interventional cardiovascular medicine.
The Impella CP with SmartAssist heart pump is a minimally invasive, temporary heart pump that uses real-time intelligence associated with improved survival and heart recovery. (Graphic: Business Wire)

Here is a recap of what DAIC viewers found most interesting during the month of September:

1. Unloading with Impella for 30 Minutes Before PCI Associated with Reduced Infarct Size in STEMI Patients

2. Cardiac Arrest Survival Rate Rising

October 3, 2022 — scPharmaceuticals Inc., a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced two poster presentations, including a late breaker, at the Heart Failure Society of America (HFSA) 2022 Annual Meeting, which is being held September 30 – October 3, in Washington DC. 

October 3, 2022 — Mawi, creators of AI-powered 

October 3, 2022 — A new ‘ECHO lab’ at Memorial Hospital West is benefiting patients that may have heart disease and the cardiac specialists that treat them. 

September 29, 2022 —  HeartBeam, Inc., a cardiac technology company that has developed the first and only 3D-vector ECG platform for heart attack detection anytime, anywhere, announced that its patent that enables generation of a synthesized 12-lead ECG by the HeartBeam AIMIGo credit card-sized device was issued by the United States Patent and Trademark Office. The innovation opens the pathway for a patient to record a set of signals using HeartBeam AIMIGo outside of a medical setting with a diagnostic synthesized 12-lead ECG immediately transmitted to a physician for review and diagnosis.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now